Unknown

Dataset Information

0

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.


ABSTRACT: Analyzing EGFR mutations and detecting ALK gene fusion are indispensable when planning to treat pulmonary adenocarcinoma. Malignant pleural effusion (MPE) is a devastating complication of lung cancer and sometimes the only source for mutation analysis. The percentage of tumor cells in the pleural effusion may be low; therefore, mutant enrichment is required for a successful analysis. The EGFR mutation status in MPE was determined using three methods: (1) PCR sequencing of genomic DNA (direct sequencing), (2) mutant-enriched PCR sequencing of genomic DNA using peptide nucleic acid (PNA-sequencing), and (3) PCR sequencing of cDNA after reverse transcription for cellular RNA (RNA-sequencing). RT-PCR was also used to test cases for ALK gene fusion. PNA-sequencing and RNA-sequencing had similar analytical sensitivities (< 1%), which indicates similar enrichment capabilities. The clinical sensitivity in 133 cases when detecting the common EGFR exon 19 and exon 21 mutations was 56.4% (75/133) for direct sequencing, 63.2% (84/133) for PNA-sequencing, and 65.4% (87/133) for RNA-sequencing. RT-PCR and sequencing showed 5 cases (3.8%) with ALK gene fusion. All had wild-type EGFR. For EGFR analysis of MPE, RNA-sequencing is at least as sensitive as PNA-sequencing but not limited to specific mutations. Detecting ALK fusion can be incorporated in the same RNA workflow. Therefore, RNA is a better source for comprehensive molecular diagnoses in MPE.

SUBMITTER: Chen YL 

PROVIDER: S-EPMC4924845 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

altmetric image

Publications

Epidermal Growth Factor Receptor Mutation and Anaplastic Lymphoma Kinase Gene Fusion: Detection in Malignant Pleural Effusion by RNA or PNA Analysis.

Chen Yi-Lin YL   Lee Chung-Ta CT   Lu Cheng-Chan CC   Yang Shu-Ching SC   Chen Wan-Li WL   Lee Yang-Cheng YC   Yang Chung-Hsien CH   Peng Shu-Ling SL   Su Wu-Chou WC   Chow Nan-Haw NH   Ho Chung-Liang CL  

PloS one 20160628 6


Analyzing EGFR mutations and detecting ALK gene fusion are indispensable when planning to treat pulmonary adenocarcinoma. Malignant pleural effusion (MPE) is a devastating complication of lung cancer and sometimes the only source for mutation analysis. The percentage of tumor cells in the pleural effusion may be low; therefore, mutant enrichment is required for a successful analysis. The EGFR mutation status in MPE was determined using three methods: (1) PCR sequencing of genomic DNA (direct seq  ...[more]

Similar Datasets

| S-EPMC6984433 | biostudies-literature
| S-EPMC6756716 | biostudies-literature
| S-EPMC7695997 | biostudies-literature
2022-10-14 | PXD035884 | Pride
| S-EPMC4497757 | biostudies-literature
| S-EPMC7209204 | biostudies-literature
| S-EPMC9487241 | biostudies-literature
| S-EPMC5650050 | biostudies-literature
| S-EPMC5440809 | biostudies-literature
| S-EPMC9691121 | biostudies-literature